Acute kidney injury (AKI) occurs in approximately 20 % of hospitalized patients with cirrhosis and is associated with increased mortality. The most common causes of AKI…
In this series, we will talk about the natural history of variceal bleeding, current standard of care, patients defined as high risk for treatment failure,…
In a follow-up to an outstanding overview of NSBB therapy in liver disease, Part 2 of this series by Anahita Rabiee presents evidence in support of earlier use of NSBBs in cirrhosis. Read on!
In the first post from new LFN author Anahita Rabiee, we are gifted an authoritative review on the Whys and Hows of beta-blockade in decompensated cirrhosis! You definitely want to read this one!